| Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug CG Benitez-Cardoza, JL Vique-Sanchez Life sciences 256, 117970, 2020 | 67 | 2020 |
| Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking JL Vique-Sánchez Bioorganic & Medicinal Chemistry 33, 116040, 2021 | 40 | 2021 |
| Developing a new drug against trichomoniasis, new inhibitory compounds of the protein triosephosphate isomerase JL Vique-Sánchez, LA Caro-Gómez, LG Brieba, CG Benítez-Cardoza Parasitology International 76, 102086, 2020 | 22 | 2020 |
| México con alta prevalencia de enfermedades crónico-degenerativas y factores de riesgo que favorecen desarrollar COVID-19 JL Vique Sánchez, O Galindo Hernández Nutr Clín Diet Hosp 2, 55-60, 2021 | 15 | 2021 |
| Amoebicidal effect of 5,5′‐[(4‐nitrophenyl)methylene]bis‐6‐hydroxy‐2‐mercapto‐3‐methyl‐4(3H)‐pyrimidinone), a new drug against Entamoeba histolytica JL Vique‐Sánchez, A Jiménez‐Pineda, CG Benítez‐Cardoza Archiv der Pharmazie 354 (2), 2000263, 2021 | 13 | 2021 |
| Exploring the conformational space of Bcl-2 protein variants: dynamic contributions of the flexible loop domain and transmembrane region LA Caro-Gómez, JL Rosas-Trigueros, E Mixcoha, JL Vique-Sánchez, ... Molecules 24 (21), 3896, 2019 | 13 | 2019 |
| Triosephosphate isomerase as a therapeutic target against trichomoniasis CG Benítez-Cardoza, LG Brieba, R Arroyo, A Rojo-Domínguez, ... Molecular and Biochemical Parasitology 246, 111413, 2021 | 11 | 2021 |
| Esters of quinoxaline-7-carboxylate-1, 4-di-N-oxide as Trichomonas vaginalis triosephosphate isomerase inhibitors I Palos, R Moo-Puc, JL Vique-Sánchez, CG Benitez-Cardoza, A Monge, ... Acta Pharmaceutica 71 (3), 485-495, 2021 | 10 | 2021 |
| A competent catalytic active site is necessary for substrate induced dimer assembly in triosephosphate isomerase P Jimenez-Sandoval, JL Vique-Sanchez, ML Hidalgo, ... Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1865 (11), 1423-1432, 2017 | 10 | 2017 |
| Identifying compounds that prevent the binding of the SARS-CoV-2 S-protein to ACE2 CG Benítez-Cardoza, JL Vique-Sánchez Computers in Biology and Medicine 136, 104719, 2021 | 7 | 2021 |
| Effects of W100E-Leptin in streptozotocin-induced diabetic mice 铆tez-CardozaBen Clinical Nutrition and Hospital Dietetics 40 (3), 153-161, 2020 | 6 | 2020 |
| Identification of pharmacological targets combining docking and molecular dynamics simulations I Ilizaliturri-Flores, JL Rosas-Trigueros, JP Carrillo-Vazquez, ... American Journal of Agricultural and Biological Sciences 8 (1), 89, 2013 | 6 | 2013 |
| AXL inhibitors selected by molecular docking: Option for reducing SARS-CoV-2 entry into cells O Galindo-Hernández, JL Vique-Sánchez Acta Pharmaceutica 72 (3), 329-343, 2022 | 5 | 2022 |
| México con mayor riesgo ante el COVID-19, factores de riesgo que pueden aumentar la ECA2 JL Vique-Sánchez, O Galindo-Hernández Nutrición clínica y dietética hospitalaria 41 (1), 2021 | 5 | 2021 |
| Triosephosphate Isomerase Inhibitors as Potential Drugs against Clostridium perfringens CG Benítez‐Cardoza, DA Fernández‐Velasco, JL Vique‐Sánchez ChemistrySelect 5 (7), 2365-2370, 2020 | 5 | 2020 |
| Potential inhibitors of the OTUB1 catalytic site to develop an anti-cancer drug using in-silico approaches O Galindo-Hernández, LA García-Salazar, VG García-González, ... Reports of Biochemistry & Molecular Biology 11 (4), 684, 2023 | 4 | 2023 |
| Acupuncture as a complementary medicine for depression caused by the confinement by COVID-19 JL Vique-Sánchez, AI Galíndez-Fuentes Revista Internacional de Acupuntura 15 (3), 100148, 2021 | 4 | 2021 |
| Potential Site to Direct Selective Compounds in the Triosephosphate Isomerase for the Development of New Drugs CG Benítez‐Cardoza, A Jiménez‐Pineda, SI Angles‐Falconi, ... ChemistrySelect 5 (16), 4866-4874, 2020 | 4 | 2020 |
| γ-Secretase Inhibitors Selected by Molecular Docking, to Develop a New Drug Against Alzheimer's Disease CH Trasviña-Arenas, LAA Medina, JL Vique-Sánchez Reports of Biochemistry & Molecular Biology 12 (2), 340, 2023 | 2 | 2023 |
| Compounds Interacting with Cholecystokinin as Potential Drugs Against Excessive Weight Gain and Obesity JL Vique‐Sánchez, PG López Lujano, KA Rodríguez Fonseca, ... ChemistrySelect 8 (16), e202300196, 2023 | 2 | 2023 |
